2026. Dose reduction of ibrutinib in chronic lymphocytic leukemia: long-term outcomes from a real-world single-center experience. Mediterranean Journal of Hematology and Infectious Diseases. 18, 1 (Oct. 2026), e2026090. DOI:https://doi.org/10.4084/MJHID.2026.090.